Vir Biotechnology Inc (VIR)
9.39
+0.02
(+0.21%)
USD |
NASDAQ |
Nov 05, 09:53
Vir Biotechnology Market Cap: 1.284B for Nov. 5, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 1.281B |
| November 01, 2024 | 1.266B |
| October 31, 2024 | 1.024B |
| October 30, 2024 | 1.039B |
| October 29, 2024 | 1.040B |
| October 28, 2024 | 1.059B |
| October 25, 2024 | 1.023B |
| October 24, 2024 | 1.005B |
| October 23, 2024 | 1.028B |
| October 22, 2024 | 1.040B |
| October 21, 2024 | 1.046B |
| October 18, 2024 | 1.043B |
| October 17, 2024 | 1.055B |
| October 16, 2024 | 1.076B |
| October 15, 2024 | 1.059B |
| October 14, 2024 | 1.049B |
| October 11, 2024 | 1.038B |
| October 10, 2024 | 1.003B |
| October 09, 2024 | 1.002B |
| October 08, 2024 | 1.001B |
| October 07, 2024 | 1.012B |
| October 04, 2024 | 1.058B |
| October 03, 2024 | 1.002B |
| October 02, 2024 | 1.050B |
| October 01, 2024 | 1.034B |
| Date | Value |
|---|---|
| September 30, 2024 | 1.024B |
| September 27, 2024 | 1.029B |
| September 26, 2024 | 997.47M |
| September 25, 2024 | 992.00M |
| September 24, 2024 | 1.030B |
| September 23, 2024 | 1.038B |
| September 20, 2024 | 1.060B |
| September 19, 2024 | 1.085B |
| September 18, 2024 | 1.066B |
| September 17, 2024 | 1.084B |
| September 16, 2024 | 1.075B |
| September 13, 2024 | 1.108B |
| September 12, 2024 | 1.074B |
| September 11, 2024 | 1.070B |
| September 10, 2024 | 1.090B |
| September 09, 2024 | 1.069B |
| September 06, 2024 | 1.060B |
| September 05, 2024 | 1.045B |
| September 04, 2024 | 1.038B |
| September 03, 2024 | 1.063B |
| August 30, 2024 | 1.129B |
| August 29, 2024 | 1.134B |
| August 28, 2024 | 1.130B |
| August 27, 2024 | 1.141B |
| August 26, 2024 | 1.178B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
992.00M
Minimum
Sep 25 2024
10.58B
Maximum
Jan 27 2021
3.427B
Average
3.362B
Median
Apr 19 2023
Market Cap Benchmarks
| Pfizer Inc | 157.08B |
| Biomarin Pharmaceutical Inc | 12.58B |
| Arbutus Biopharma Corp | 723.04M |
| GlycoMimetics Inc | 26.08M |
| FibroGen Inc | 31.12M |
Market Cap Related Metrics
| PS Ratio | 20.54 |
| Price to Book Value | 1.035 |
| Price | 9.39 |
| Earnings Yield | -41.75% |